Skip to main content

Table 3 Medication abortion counseling: comparing pharmacist survey and Mystery Clients

From: Knowledge, provision of information and barriers to high quality medication abortion provision by pharmacists in Uttar Pradesh, India

 

Pharmacist Survey N = 283 N (%)

Mystery Client N = 111

N (%)

Determines gestational age, and if so, how?

 Does not determine the estational age

13 (4.59)

No info

 Trust on client saying

155 (57.41)

No info

 Based on last menstrual period

180 (66.67)

85 (76.58)

 As per doctor assessment/report

66 (24.44)

No info

 Other

1 (0.37)

No info

Asked if she had taken a pregnancy test

 

97 (87.39)

Tell clients to have anywhere between a 24–48 h gap between mifepristone and misoprostol

207 (73.14)

60 (55.56)

Don’t know

21 (7.42)

No info

Reported taking all 4 misoprostol tablets together (800 mcg total)

51 (18.02)

No info

Don’t know

21 (7.42)

No info

Reported taking misoprostol tablets in two doses of 2 pills (800 mcg total)

109 (38.51)

No info

Route to take misoprostol

 Oral

256 (90.46)

99 (89.19)

 Vaginal

114 (40.28)

12 (10.81)

 Sublingual

20 (7.1)

3 (2.70)

 Buccal

9 (3.2)

3 (2.70)

 Other

4 (1.4)

0 (0)

 Don’t know/Told nothing

11 (3.9)

4 (3.60)

Potential side effects/reactions to MA told to clients

 Does not tell MA clients about possible reactions (side effects) to MA

88 (31.1)

15 (13.51)

 Nausea/vomiting

65 (33.3)

9 (8.11)

 Headache

31 (15.9)

1 (0.90)

 Diarrhea

4 (2.1)

 

 Lower abdomen pain

72 (36.92)

62 (55.86)

 Heavy bleeding

169 (86.67)

43 (38.74)

 Dizziness/weakness

37 (19)

29 (26.13)

 Fever

12 (6.15)

 

 Other

41 (21)

3 (2.70)